SEP 16, 2014

Advanced Genomics in Clinical and Translational Research - Informing end-to-end cancer drug development with bioinformatics

24 32 16192

This event will highlight the innovative use of big data to inform cancer drug development and transform cancer clinical development. The wealth of curated and well-annotated cancer genomic and clinical trial data within the Oncomine® Knowledgebase powers a broad variety of systematic bioinformatics analysis. Several of the top pharma companies have utilized our services and software to help identify and understand relevant biomarkers and their potential for efficient and effective drug development strategies.

A group of scientists has been assembled to cover topics such as:



  • Expanding the potential of your drug programs with portfolio prioritization & label extension opportunities
  • Selecting the right population for your clinical trial
  • Exploring combination therapies based on biomarkers of sensitivity and resistance

This event intends to bring together drug developers, from executives to research scientists, to learn about advances in cancer bioinformatics.

This webinar offers an amazing opportunity, as it is free to participants and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues without leaving the comfort of their office or home.

Webinar participants will be able to:





  • Attend interactive live streaming video sessions
  • Have their questions answered in real time
  • Chat live with peers and speakers
  • Browse our exhibit booth for a spectrum of products




Show Resources
  • SEP 16, 2014 08:30 AM PDT
    Speaker: Mary Ellen Urick, PhD
  • SEP 16, 2014 09:30 AM PDT
    Speaker: Nickolay Khazanov, PhD
  • SEP 16, 2014 10:00 AM PDT
    Speaker: Sean Eddy, PhD
  • Sessions
  • SEP 16, 2014 08:30 AM PDT
    Speaker: Mary Ellen Urick, PhD
  • SEP 16, 2014 09:30 AM PDT
    Speaker: Nickolay Khazanov, PhD
  • SEP 16, 2014 10:00 AM PDT
    Speaker: Sean Eddy, PhD

  • Emma Bowden, PhD
    Director, Translational Medicine, Thermo-Fisher Scientific
      With Thermo Fisher Scientific, Dr. Bowden leads Pharma Client Services to provide custom bioinformatics solutions for oncology drug development and research. This group develops complete solutions from target discovery and validation, predictive biomarkers of response and drug combination synergies, to clinical testing hypotheses   Dr. Bowden has more than 18 years of research and leadership experience in cancer biology and drug development in both academic and industry settings. She has served as an Assistant Professor at Georgetown University. While in industry, Dr. Bowden led multiple preclinical projects and strategy area teams supporting the development of various types of biologic including antibodies, multispecifics and antibody-drug conjugates. She holds a PhD in Biochemistry from University of Bristol. 
    • Mary Ellen Urick, PhD
      Staff Scientist, Bioinformatics, Thermo Fisher Scientific
    • Nickolay Khazanov, PhD
      Staff Scientist, Bioinformatics, Thermo Fisher Scientific
        Dr. Khazanov works as a Bioinformatics Scientist on the Compendia Bioscience™ Translational Bioinformatics Services team, part of Thermo Fisher Scientific. In this role, Dr. Khazanov works with translational scientists to identify potential novel drug targets and to characterize drug-response biomarkers using large sets of data from tumor samples. He earned his doctorate in Bioinformatics from the University of Michigan in 2011, where he worked on structural bioinformatics methods for computational drug design
      • Sean Eddy, PhD
        Staff Scientist, Bioinformatics, Thermo Fisher Scientific
          Dr. Eddy joined the Compendia Bioscience™ Translational Bioinformatics Services team, now part of Thermo Fisher Scientific, in July 2010. In his current position, Dr. Eddy provides oncology genomic solutions including but not limited to: identification and cataloging of actionable cancer driving genetic variants, assisting pharmaceutical partners in the identification/validation of novel drug targets, and the identification of potentially clinically relevant biomarkers using the Oncomine® Platform.  Prior to joining Thermo Fisher Scientific, he was employed as a scientist at Genstruct, Inc. in Cambridge, Massachusettes where he interrogated transcriptional regulatory networks to identify mechanisms of cancer progression, disease recurrence, drug-induced toxicity and drug resistance. He earned his doctorate from Carleton University in 1998 by characterizing the role that the PI3K/AKT and PPAR-gamma pathways in stress adaptation. He subsequently completed his postdoctoral studies at Boston University School of Medicine characterizing kinase signaling networks in breast cancer, and implicated IKBKE as having an oncogenic role in progression of the disease.
        Sponsored By

        For information on becoming a sponsor or exhibitor, please click here.


        General LabRoots Questions

        For bugs, spam, technical support or questions please call +1-714-463-4673 or email  
        Contact us

        Virtual Events and Webinars

        Supported Configurations

        • Operating System Internet Explorer Firefox Chrome Safari
          Vista IE8+ FF10+ Chrome15+
          Windows 7 IE8+ FF10+ Chrome15+
          Windows 8 IE10 FF10+ Chrome15+
          Mac OS X   FF10+ Chrome15+ Safari5.1+
        • Cookie settings: session cookies enabled
        • Browser configuration must have JavaScript enabled
        • Adobe Flash player 10.2 or later

        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

        Internet Connection

        • A minimum of 100Kbps is recommended for audio-only events
        • A minimum of 300Kbps is recommended for speaker on-video events

        Computer Equipment

        • Screen Resolution: Minimum 1024x768
        • Video Card: 65,000 colors minimum
        • Sound card and speakers (or headphones) for hearing webcast in full format
        • Audio Card: 16-bit minimum
        • RAM: 512MB of free RAM

        Firewall Protocol

        • HTTP on port 80 or HTTPS on port 443
        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

        Work-At-Home Attendees

        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

        For A Seamless Experience

        When using a mobile device, FREE Mobile Apps are available:

        - For viewing Webinars:

        - For viewing Virtual Events

        Attendee Guide

        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

        Virtual Event and Webinar Support:

        Continuing Education (CME/CE) Support

        Loading Comments...